logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Andrew W. Hahn

The University of Texas MD Anderson Cancer Center
H指数:27
被引数:2,375

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cardiometabolic health’s influence on the efficacy of pre-operative hormone therapy for men with localized high-risk prostate cancer

心血管代谢健康对局部高危前列腺癌男性患者术前激素治疗效果的影响

Prostate Cancer and Prostatic Diseases
IF5.8
2026-10-150
OAAI
Mitchell Boshkos; Maria Julia Moura Nascimento Santos; Rebecca S. Tidwell; Neha Venkatesh; Sagar S. Mukhida; Patrick G. Pilie; Sumit K. Subudhi; Paul G. Corn; Ana M. Aparicio; Bilal A. Siddiqui; Debanjan Pain; Efstratios Koutroumpakis; Amado J. Zurita; Daniel E. Frigo; Justin R. Gregg; Christopher J. Logothetis; Johannes F. Fahrmann; Andrew W. Hahn
Evolving strategies in prostate cancer: Emerging approaches and unmet needs from the Bridging the Gaps in Prostate Cancer expert panel

前列腺癌的演变策略：来自“弥合前列腺癌差距”专家小组的 emerging approaches 和 unmet needs

Cancer
IF5.1
2026-02-110
OAAI
Rana R. McKay MD, FASCO; Benjamin L. Maughan MD, PharmD; Alicia K. Morgans MD, MPH, FASCO; Neal D. Shore MD, FACS; Evan Y. Yu MD; Ravi A. Madan MD; Jacob E. Berchuck MD; Bradley C. Carthon MD, PhD; Steven E. Finkelstein MD, DABRA, FACRO; Leonard Gomella MD, FACS; Michael A. Gorin MD; Andrew W. Hahn MD; Stacy Loeb MD, MSc, PhD (Hon); Vivek K. Narayan MD, MS; Daniel P. Petrylak MD; Charles J. Ryan MD; Karine Tawagi MD; Phuoc T. Tran MD, PhD; Tanya Dorff MD
A multicenter randomized phase II trial of lenvatinib plus everolimus versus cabozantinib in patients with metastatic clear cell RCC that progressed on PD-1 immune checkpoint inhibition (LenCabo)

一项多中心随机II期试验，比较仑伐替尼联合依维莫司与卡博替尼在PD-1免疫检查点抑制剂进展后的转移性透明细胞肾细胞癌患者中的疗效（LenCabo）。

Annals of Oncology
IF65.4
2025-10-180
PRE
A.W. Hahn; J. Chahoud; W.P. Skelton; Y. Yuan; A.J. Zurita; C. Kovitz; O. Alhalabi; M.T. Campbell; E. Jonasch; J. Lin; M. Desai; M.J.M.N. Santos; H. Hwang; P.G. Corn; P. Msaouel; N.M. Tannir
20Phase II trial of ivonescimab in patients with advanced clear cell renal cell carcinoma previously treated with immune checkpoint blockade: IVORY trial (NCT06940518)

II期临床试验：评估ivonescimab在既往接受过免疫检查点阻断治疗的晚期透明细胞肾细胞癌患者中的疗效（IVORY试验，NCT06940518）。

ONCOLOGIST
IF4.2
2025-10-010
OAAI
Dizman, Nazli; Slack-Tidwell, Rebecca S.; Sheth, Rahul A.; Alhalabi, Omar; Campbell, Matthew T.; Corn, Paul G.; Goswami, Sangeeta; Johns, Andrew; Jonasch, Eric; Lin, John K.; Shah, Amishi Y.; Wang, Jianbo; Zurita-Saavedra, Amado J.; Gao, Jianjun; Tannir, Nizar; Hahn, Andrew W.; Msaouel, Pavlos
Differences in Methamphetamine Use, Self-Reported Impact, and HIV-Related Outcomes by Gender and Sexual Orientation in a Multisite U.S. Cohort of People with HIV in Care

美国多中心HIV感染者队列中，不同性别和性取向人群在甲基苯丙胺使用、自报影响及HIV相关结局方面的差异

AIDS and Behavior
IF2.4
2025-09-290
PRE
R.J. Fredericksen; R.M. Nance; L.N. Drumright; L.S. Mixson; S.A. Ruderman; B.M. Whitney; C. Fahey; K.H. Mayer; J.P. Jain; M. Saag; J. Eron; S. Napravnik; L. Bamford; E. Cachay; G.A. Yendewa; J. Keruly; R.D. Moore; A. Rodriguez; S. Safren; J.A.C. Delaney; H.M. Crane; A.W. Hahn
Metastasis-directed radiotherapy without systemic therapy for oligometastatic clear-cell renal-cell carcinoma: primary efficacy analysis of a single-arm, single-centre, phase 2 trial

寡转移性透明细胞肾细胞癌的转移灶定向放射治疗（无系统性治疗）：一项单臂、单中心、II期试验的主要疗效分析

lancet oncology
IF0
2025-09-040
PRE
Chad Tang; Alexander D Sherry; Aaron Seo; Kieko Hara; Haesun Choi; Suyu Liu; Xiaowen Sun; Anya Montoya; Ethan B Ludmir; Amishi Y Shah; Eric Jonasch; Amado J Zurita; Craig Kovitz; Omar Alhalabi; Sangeeta Goswami; Andrew W Hahn; Matthew T Campbell; Arianna Hernandez; Kevin T Nead; Peter Van Loo; Shiqin Su; Christopher J Battey; Matthew L LaBella; Sarah Ratzel; Ashley Acevedo; Giannicola Genovese; Kanishka Sircar; Jose A Karam; Nizar M Tannir; Pavlos Msaouel
Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance
BIOMARKER RESEARCH
IF11.5
2024-11-090
OAAI
Gregg, Justin R.; Newcomb, Lisa; Wu, Ranran; Dennison, Jennifer; Davis, John W.; Pettaway, Curtis; Pisters, Louis; Ward, John F.; Chapin, Brian F.; Chery, Lisly; Urkmez, Ahmet; Fang, Andrew M.; Higgason, Noel; Troncoso, Patricia; Daniel, Carrie R.; Logothetis, Christopher; Thompson, Timothy C.; Hahn, Andrew W.; Liu, Menghan; Zheng, Yingye; Lin, Dan W.; Hanash, Samir; Irajizad, Ehsan; Fahrmann, Johannes
Body composition as a determinant of the therapeutic index with androgen signaling inhibition
PROSTATE CANCER AND PROSTATIC DISEASES
IF5.8
2024-07-172
PRE
Hahn, Andrew W.; Tidwell, Rebecca S.; Pilie, Patrick G.; Yu, Yao; Liu, Jingjing; Surasi, Devaki Shilpa; Titus, Mark; Zhang, Jianhua; Venkatesh, Neha; Panaretakis, Theocharis; Gregg, Justin R.; Zurita, Amado J.; Siddiqui, Bilal A.; Corn, Paul G.; Subudhi, Sumit K.; Msaouel, Pavlos; Koutroumpakis, Efstratios; Huff, Chad D.; Aparicio, Ana; McQuade, Jennifer L.; Frigo, Daniel E.; Logothetis, Christopher J.
A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates

阿帕鲁胺治疗中危前列腺癌的II期试验及其分子相关性

BJU INTERNATIONAL
IF4.4
2024-06-041
PRE
Hahn, Andrew W.; Manyam, Ganiraju C.; Chapin, Brian F.; Zhang, Miao; Yu, Yao; Pettaway, Curtis A.; Chery, Lisly; Pisters, Louis L.; Ward, John F.; Gregg, Justin R.; Papadopoulos, John; Kamat, Ashish M.; Lozano, Marisa; Hoang, Anh; Broom, Bradley; Wang, Xuemei; Huff, Chad D.; Logothetis, Christopher J.; Troncoso, Patricia; Pilie, Patrick G.; Davis, John W.
Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Progressing on Enzalutamide
CLINICAL CANCER RESEARCH
IF10.2
2024-01-167
PRE
Abida, Wassim; Hahn, Andrew W.; Shore, Neal; Agarwal, Neeraj; Sieber, Paul; Smith, Matthew R.; Dorff, Tanya; Monk, Paul; Rettig, Matthew; Patel, Rupal; Page, Anne; Duff, Maureen; Xu, Rongda; Wang, Jian; Barkund, Shravani; Pankov, Aleksandr; Wang, Amber; Junttila, Melissa R.; Multani, Pratik S.; Daemen, Anneleen; Chow Maneval, Edna; Logothetis, Christopher J.; Morris, Michael J.

研究方向

暂未获取到该数据
N
Nizar M. Tannir
H 指数:83论文数:1,046被引数:3.1万
N
Neeraj Agarwal
H 指数:6论文数:45被引数:444
M
Matthew T. Campbell
H 指数:33论文数:403被引数:8,276
A
Amado J. Zurita
H 指数:36论文数:352被引数:5,414
C
Christopher J. Logothetis
H 指数:122论文数:1,148被引数:8.6万
A
Amishi Y. Shah
H 指数:32论文数:290被引数:5,322
B
Benjamin L. Maughan
H 指数:29论文数:393被引数:3,280
R
Roberto Nussenzveig
H 指数:28论文数:203被引数:3,026
P
Pavlos Msaouel
H 指数:43论文数:580被引数:6,348
N
Neeraj Agarwal
H 指数:48论文数:454被引数:1.3万